These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36255451)

  • 1. Quantitative Data-Independent Acquisition Mass Spectrometry Proteomics and Weighted Correlation Network Analysis of Plasma Samples for the Discovery of Chronic Kidney Disease-Specific Atherosclerosis Risk Factors.
    Dai D; Cheng Z; Feng S; Zhu Z; Yu J; Zhang W; Lu H; Zhang R; Zhu J
    DNA Cell Biol; 2022 Nov; 41(11):966-980. PubMed ID: 36255451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry.
    Luczak M; Formanowicz D; Marczak Ł; Pawliczak E; Wanic-Kossowska M; Figlerowicz M; Stobiecki M
    J Transl Med; 2015 Jan; 13():20. PubMed ID: 25622820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-Free Quantitative Proteomics Reveals Differences in Molecular Mechanism of Atherosclerosis Related and Non-Related to Chronic Kidney Disease.
    Luczak M; Suszynska-Zajczyk J; Marczak L; Formanowicz D; Pawliczak E; Wanic-Kossowska M; Stobiecki M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27144566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisample Mass Spectrometry-Based Approach for Discovering Injury Markers in Chronic Kidney Disease.
    Kim JE; Han D; Jeong JS; Moon JJ; Moon HK; Lee S; Kim YC; Yoo KD; Lee JW; Kim DK; Kwon YJ; Kim YS; Yang SH
    Mol Cell Proteomics; 2021; 20():100037. PubMed ID: 33453410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key pathways and genes in different types of chronic kidney disease based on WGCNA.
    Guo Y; Ma J; Xiao L; Fang J; Li G; Zhang L; Xu L; Lai X; Pan G; Chen Z
    Mol Med Rep; 2019 Sep; 20(3):2245-2257. PubMed ID: 31257514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted Gene Correlation Network Analysis (WGCNA) Detected Loss of MAGI2 Promotes Chronic Kidney Disease (CKD) by Podocyte Damage.
    Zuo Z; Shen JX; Pan Y; Pu J; Li YG; Shao XH; Wang WP
    Cell Physiol Biochem; 2018; 51(1):244-261. PubMed ID: 30448842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The key candidate genes in tubulointerstitial injury of chronic kidney diseases patients as determined by bioinformatic analysis.
    Wang W; Shen J; Qi C; Pu J; Chen H; Zuo Z
    Cell Biochem Funct; 2020 Aug; 38(6):761-772. PubMed ID: 32340064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease is associated with increased coronary artery atherosclerosis as revealed by multidetector computed tomographic angiography.
    Roy SK; Cespedes A; Li D; Choi TY; Budoff MJ
    Tex Heart Inst J; 2012; 39(6):811-6. PubMed ID: 23304018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Important Modules and Hub Gene in Chronic Kidney Disease Based on WGCNA.
    Wang J; Yin Y; Lu Q; Zhao YR; Hu YJ; Hu YZ; Wang ZY
    J Immunol Res; 2022; 2022():4615292. PubMed ID: 35571562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Impact of Chronic Kidney Disease on Coronary Calcification and Atherosclerosis in Asymptomatic Individuals with or without Diabetes: Analysis from a Coronary Computed Tomographic Angiography Registry.
    Choi IJ; Lim S; Choo EH; Kim JJ; Hwang BH; Kim TH; Seo SM; Koh YS; Shin DI; Park HJ; Kim PJ; Jeon DS; Lee SH; Cho JH; Jung JI; Chang K; Seung KB
    Cardiorenal Med; 2018; 8(3):228-236. PubMed ID: 29961069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chronic kidney disease on coronary plaque components in coronary artery disease patients with both diabetes mellitus and hypertension.
    Shigemoto E; Iwata A; Futami M; Kato Y; Yamashita M; Imaizumi S; Kuwano T; Ike A; Sugihara M; Saku K; Miura SI
    Heart Vessels; 2019 Jul; 34(7):1065-1075. PubMed ID: 30607540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics.
    Ku EJ; Cho KC; Lim C; Kang JW; Oh JW; Choi YR; Park JM; Han NY; Oh JJ; Oh TJ; Jang HC; Lee H; Kim KP; Choi SH
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32327445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening potential prognostic biomarkers of long non-coding RNAs for predicting the risk of chronic kidney disease.
    Li N; Cui Y; Yin M; Liu F
    Braz J Med Biol Res; 2019; 52(11):e8333. PubMed ID: 31721901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal timing of coronary angiograms for patients with chronic kidney disease: association between the duration of kidney dysfunction and SYNTAX scores.
    Song B; Dai D; Liu S; Zhu Z; Ding F; Zhu J; Zhang R
    Ren Fail; 2021 Dec; 43(1):307-312. PubMed ID: 33538236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying Proteomics and Integrative "Omics" Strategies to Decipher the Chronic Kidney Disease-Related Atherosclerosis.
    Tracz J; Luczak M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry.
    Ramírez Medina CR; Ali I; Baricevic-Jones I; Odudu A; Saleem MA; Whetton AD; Kalra PA; Geifman N
    Clin Proteomics; 2023 Apr; 20(1):19. PubMed ID: 37076799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better Prognosis After Complete Revascularization Using Contemporary Coronary Stents in Patients With Chronic Kidney Disease.
    Hwang D; Kang J; Yang HM; Yang S; Park J; Han JK; Kang HJ; Koo BK; Kim HS
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007907. PubMed ID: 31345065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study.
    Nakano T; Ninomiya T; Sumiyoshi S; Fujii H; Doi Y; Hirakata H; Tsuruya K; Iida M; Kiyohara Y; Sueishi K
    Am J Kidney Dis; 2010 Jan; 55(1):21-30. PubMed ID: 19765871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary atherosclerosis detected by coronary CT angiography in asymptomatic subjects with early chronic kidney disease.
    Cho I; Min HS; Chun EJ; Park SK; Choi Y; Blumenthal RS; Rivera JJ; Nasir K; Kim YJ; Sohn DW; Oh BH; Park YB; Chang HJ
    Atherosclerosis; 2010 Feb; 208(2):406-11. PubMed ID: 19781704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.